BIOLASE ANNOUNCES POSTIVE PRELIMINARY REVENUE RESULTS FOR 2021 FOURTH QUARTER; ENTERS 2022 WITH SIGNIFICANT MOMENTUM
BIOLASE and EdgeEndo Announce FDA 510(k) Clearance of New EdgePRO Laser-Assisted Microfluidic Irrigation Device for Endodontists
H.C. Wainwright BIOCONNECT Virtual Investor Conference
Sign Up For Email Alerts
Receive updates straight into your inboxSign up today
Reducing Fear and Anxiety Related to Dentistry
BIOLASE, Inc. is a medical device company and global market leader in the manufacturing and marketing of proprietary dental laser systems that enable dentists and dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and surgical applications. BIOLASE's laser systems are designed to provide clinically superior, patient friendly results for many types of common dental procedures compared to those achieved with traditional instruments. BIOLASE has sold over 41,200 laser systems to date in over 90 countries around the world.
BIOLASE, Inc. at a Glance
Laser systems sold (in more than 80 countries)
Approximate Patented and patent-pending technologies
Net Revenues by Category
Sales by End Market
Net Revenues by Region
For complete information regarding our financials, see our periodic filings.
27042 Towne Centre Drive
Foothill Ranch, CA 92610-2811
EVC Group LLC
EVC Group LLC
Computershare Trust Company, N.A.